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n this study, we have sought to determine whether
 
utrophin transcripts are targeted to a distinct subcellular
compartment in skeletal muscle cells, and have examined
 
the role of the 3
 
  
 
untranslated region (UTR) in regulating
 
the stability and localization of utrophin transcripts. Our
 
results show that utrophin transcripts associate preferentially
with cytoskeleton-bound polysomes via actin microﬁlaments.
Because this association is not evident in myoblasts, our
findings also indicate that the localization of utrophin
transcripts with cytoskeleton-bound polysomes is under
developmental inﬂuences. Transfection of LacZ reporter
constructs containing the utrophin 3
 
 
 
UTR showed that this
I
 
region is critical for targeting chimeric mRNAs to cytoskeleton-
bound polysomes and controlling transcript stability.
 
Deletion studies resulted in the identiﬁcation of distinct
 
regions within the 3
 
 
 
UTR responsible for targeting and
 
stabilizing utrophin mRNAs. Together, these results illustrate
the contribution of posttranscriptional events in the regulation
of utrophin in skeletal muscle. Accordingly, these ﬁndings
provide novel targets, in addition to transcriptional events,
for which pharmacological interventions may be envisaged
to ultimately increase the endogenous levels of utrophin in
skeletal muscle ﬁbers from Duchenne muscular dystrophy
(DMD) patients.
 
Introduction
 
Duchenne muscular dystrophy (DMD)* is the most prev-
 
alent inherited neuromuscular disorder affecting 
 
 
 
1 in
 
every 3,500 male births (Emery, 1991). The disease results
from mutations and/or deletions in the X-linked dystro-
phin gene which prevents production of a large cytoskeletal
protein of the spectrin superfamily (Ahn and Kunkel,
1993; Worton, 1995). Although the exact function of dys-
trophin remains unclear, it has been shown to serve as a
link between the internal actin cytoskeleton and the extra-
cellular matrix via a complex of dystrophin-associated pro-
teins (Matsumura and Campbell, 1994; Blake et al., 1996).
Through these interactions, dystrophin is thought to main-
tain the integrity of muscle fibers during cycles of muscle
contraction and relaxation.
Several years ago, a multiexonic gene on chromosome 6
that encodes a large cytoskeletal protein showing extensive
sequence identity with dystrophin was identified (Love et
al., 1989; Tinsley et al., 1992). Interestingly, this protein,
now referred to as utrophin, is more ubiquitously distrib-
uted than full-length dystrophin. In skeletal muscle fibers,
utrophin also displays a clear difference in its pattern of
distribution as compared with dystrophin. Indeed, whereas
dystrophin is known to be expressed along the entire
length of the sarcolemma in normal muscle fibers, utro-
phin preferentially accumulates at the level of the neuro-
muscular junction in both normal and DMD muscles
(Matsumura and Campbell, 1994; Blake et al., 1996;
Gramolini et al., 2000) where it may contribute to the full
differentiation of the postsynaptic apparatus (Deconinck et
al., 1997; Grady et al., 1997). Because of its high degree of
identity with dystrophin and its capacity to bind dystro-
phin-associated proteins (Matsumura et al., 1992), it has
been suggested that upregulation of utrophin into extra-
synaptic regions of DMD muscle fibers could serve as an
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adequate therapeutic strategy for this disease (Blake et al.,
1996; Gramolini et al., 2000). Indeed, a series of experi-
ments using transgenic mouse model systems has shown
that increased expression of utrophin along dystrophic
muscle fibers functionally compensates for the lack of dys-
trophin, and hence prevents the development of the mus-
cle pathology (see, for example, Tinsley et al., 1996).
Therefore, it is of interest to understand the mechanisms
presiding over utrophin expression in attempts to ulti-
mately increase expression of the endogenous gene product
throughout DMD muscle fibers.
We have recently undertaken a series of experiments to
gain insights into the nature of these mechanisms (Gramo-
lini et al., 2000). In a first set of studies, we have shown
that utrophin transcripts display an asymmetric distribu-
tion along skeletal muscle fibers, as they are clearly en-
riched within the postsynaptic sarcoplasm (Gramolini et
al., 1997; Vater et al., 1998). Subsequent work further
demonstrated that local transcriptional activation of the
utrophin gene within myonuclei located in the postsynap-
tic sarcoplasm accounts, at least in part, for the preferen-
tial accumulation of utrophin mRNAs within this region
of muscle fibers (Gramolini et al., 1997, 1998, 1999a;
Khurana et al., 1999). However, under distinct experimen-
tal conditions we have also observed that utrophin may be
regulated via posttranscriptional events (Gramolini et al.,
1999b). In particular, we have recently shown that in-
creased mRNA stability accounts for the higher levels of
utrophin seen in slow versus fast skeletal muscles, thereby
implicating the contribution of posttranscriptional events
in the overall regulation of utrophin expression (Gramolini
et al., 2001). In this context, it is interesting to note that
posttranscriptional as well as translational regulatory mech-
 
anisms have recently been shown to contribute to the de-
velopment and maintenance of neuromuscular junctions in
 
Drosophila
 
 (Sigrist et al., 2000).
The targeting of distinct mRNAs to specific subcellular
compartments has recently emerged as a key posttranscrip-
tional event involved in the control of protein expression
and localization. For instance, mRNAs such as 
 
bicoid
 
, 
 
oskar,
 
and 
 
Vg
 
1 become localized to a specific pole in developing
 
Xenopus
 
 and 
 
Drosophila
 
 oocytes (see, for example, Pondel
and King, 1988; Kim-Ha et al., 1993; Forristall et al.,
1995). Interestingly, similar mRNA targeting mechanisms
have also been observed in a variety of mammalian cells (see,
for example, Bruckenstein et al., 1990; Burgin et al., 1990;
Cripe et al., 1993; Kislauskis et al., 1994). In some cases, the
subcellular localization of mRNAs has been shown to in-
volve their targeting to specific pools of polysomes which as-
sociate with the cytoskeleton through regulatory sequences
contained within the 3
 
 
 
UTR (Hesketh et al., 1994; Veyrune
et al., 1996; Tsai et al., 1997; Bagni et al., 2000; Mori et al.,
2000). Such subcellular localization of mRNAs is now rec-
ognized as a key step that facilitates the sorting and targeting
of proteins, while also promoting their assembly into macro-
molecular complexes (for review see St Johnston, 1995;
Hovland et al., 1996; Bassell and Singer, 1997; Hazelrigg,
1998; Jansen, 2001). With this in mind, we have begun to
examine in the present study whether posttranscriptional
regulatory mechanisms control utrophin expression in skele-
tal muscle cells. Specifically, we have: (a) sought to deter-
mined whether utrophin transcripts are targeted to a distinct
subcellular compartment; and (b) examined the role of the
utrophin 3
 
  
 
untranslated region (UTR) in regulating the sta-
bility and localization of utrophin transcripts in skeletal
muscle cells.
Figure 1.  Complete sequence of the utrophin 
3 UTR. (A) Sequence of the mouse utrophin 
3 UTR. (B) Comparison between the mouse 3  
UTR and the available rat and human sequences. 
The percentage of identity with the mouse 
sequence is also shown. 
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Results
 
The utrophin 3
 
 
 
UTR
 
Cloning and sequencing of the utrophin 3
 
 
 
UTR revealed
that it is a relatively large region spanning 1,995 nucleotides
(Fig. 1 A). A detailed analysis of this RNA fragment showed
that it contains several regions of interest. For example, there
are six AU-rich elements located at nucleotide positions 479,
487, 613, 760, 840, and 1292, which consist of the se-
quence AUUUA (St Johnston, 1995; Hesketh, 1996; Vey-
rune et al., 1997). Alignment of the full-length 3
 
 
 
UTR us-
ing several data banks revealed a high degree of homology
with a partial utrophin 3
 
 
 
UTR from rat (Fig. 1 B). Specifi-
cally, the homology between mouse and rat is 
 
 
 
90%
through the first 281 nt, after which there is no available
sequence information for the rat 3
 
 
 
UTR. Interestingly, sig-
nificant homology was also observed between the mouse
3
 
 
 
UTR and a human sequence from chromosome 6 con-
taining the utrophin gene. In this case, the overall sequence
identity between the mouse and human 3
 
 
 
UTRs is close to
80%, with certain regions showing even higher homology
(Fig. 1 B). In particular, there is 
 
 
 
87% homology between
nucleotides 352 and 583 of the mouse and human se-
quences. However, our comparison also revealed that the
utrophin 3
 
 
 
UTR is quite distinct from the dystrophin
3
 
 
 
UTR. Indeed, we could not find any significant homology
between these two 3
 
 
 
 UTRs (
 
 
 
10%) despite the high se-
quence identity seen in the coding regions of these two
genes.
 
Utrophin transcripts are enriched in a
cytoskeletal-bound polysomal fraction
 
Initially, we examined the distribution of utrophin mRNAs
in different pools of polysomes by using subcellular fraction-
ation methods (Hesketh et al., 1994; Kislauskis et al., 1994;
Hovland et al., 1995; Veyrune et al., 1997). Three distinct
pools, corresponding to free, cytoskeletal-, and membrane-
bound polysomes, were biochemically isolated. For these ex-
periments, we first used several approaches to confirm that
we had successfully isolated different pools of polysomes.
Specifically, we monitored lactate dehydrogenase (LDH) ac-
tivity as previously used in this case as a positive control for
the free polysomal fraction because it contains cytosolic ele-
ments (Vedeler et al., 1991; Hovland et al., 1995; Mahon et
al., 1995). Analysis of aliquots taken from the various sub-
cellular fractions and from each sample showed that
 
  
 
90%
of the total LDH activity was present in the free polysomal
fraction (Table I). These results are in excellent agreement
with previous findings (Vedeler et al., 1991; Hovland et al.,
1995; Mahon et al., 1995). In addition, we examined the
distribution of utrophin among the different polysomal frac-
tions. As shown in Fig. 2 A, utrophin levels were clearly en-
riched within the cytoskeletal fraction as revealed by West-
ern blot analysis. Finally, we also monitored in these
fractions the presence of mRNAs encoding the acetylcholine
receptor (AChR) 
 
 
 
-subunit. Because these transcripts en-
code a membrane protein (Hovland et al., 1995), we ob-
served, as expected, that AChR 
 
 
 
-subunit mRNAs were
significantly more abundant in the membrane-bound poly-
somal fraction (Fig. 2 B).
Having established that this subcellular fractionation pro-
cedure yielded three distinct pools of polysomes, we next de-
termined the relative distribution of utrophin transcripts in
 
Table I. 
 
LDH activity in various polysomal fractions
Fraction
Control
(
 
n 
 
 
 
 12)
COL
(
 
n 
 
 
 
 4)
Cy-D
(
 
n 
 
 
 
 8)
3
 
 
 
UTR
(
 
n 
 
 
 
 12)
Myoblast
(
 
n 
 
 
 
 7)
 
Free 95.0 
 
 
 
 0.6 90.0 
 
 
 
 3.7 95.1 
 
 
 
 0.8 93.1 
 
 
 
 1.0 93.2 
 
 
 
 1.5
Cytoskeletal 3.3 
 
 
 
 0.6 9.0 
 
 
 
 3.8 3.5 
 
 
 
 0.5 4.1 
 
 
 
 0.8 3.9 
 
 
 
 1.1
Membrane 0.7 
 
 
 
 0.2 1.1 
 
 
 
 0.6 1.4 
 
 
 
 0.4 3.0 
 
 
 
 0.5 3.0 
 
 
 
 0.5
Aliquots from each polysomal fraction were assayed for LDH. As expected, the preferential activity of LDH within the free (cytosolic) polysomal fraction.
Data are expressed as a percent of the total activity.  The heading for each column represents the different experiments performed in this study, i.e., control
myotubes, myotubes treated with COL or Cy-D, myotubes transfected with reporter constructs containing the utrophin 3
 
 
 
UTR, and myoblasts used for
examining the effects of differentiation.
Figure 2.  Characterization of the polysomal fractions. Markers of 
the three distinct pools of polysomes were used to ensure the validity 
of the subcellular fractionation procedure. Activity of the cytosolic 
enzyme LDH was determined for the free polysomal fraction 
(text and Table I). (A) shows the levels of utrophin in the free (F), 
cytoskeletal (C)-, and membrane (M)-bound polysomal fractions as 
determined by Western blot analysis. (B) shows a representative 
ethidium bromide–stained agarose gel of RT-PCR products corre-
sponding to  -AChR mRNAs obtained from the three fractions. The 
left lane is a 100-bp molecular mass marker. ( ), negative control 
lane. Note the accumulation of utrophin in the cytoskeletal-bound 
fraction (B) and the enrichment of transcripts encoding the 
 -subunit of AChR in the membrane-bound polysomal fraction (C). 
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free, cytoskeletal-, and membrane-bound polysomal fractions.
Interestingly, in these experiments we observed that utrophin
mRNAs were enriched within the cytoskeletal-bound polyso-
mal fraction in 4-d-old myotubes (Fig. 3 A). In fact, our anal-
ysis revealed that 
 
 
 
65% of the total content of utrophin tran-
scripts was present within this fraction as compared with the
free and membrane-bound fractions (Fig. 3 B).
 
Utrophin transcripts associate with actin filaments
 
To further characterize the association of utrophin tran-
scripts with cytoskeletal-bound polysomes, we next dis-
rupted the integrity of actin filaments or microtubules.
Short-term treatments of myotubes with cytochalasin D
(Cy-D) resulted in the depolymerization of actin filaments
as shown by fluorescence labeling using rhodamine-conju-
gated phalloidin (Fig. 4, compare A and B). Examination of
the relative content of utrophin transcripts in polysomal
fractions isolated from control versus treated myotubes re-
vealed a dramatic redistribution of utrophin mRNAs. In
comparison to the findings seen in control myotubes, utro-
phin transcripts were clearly enriched in the cytoplasmic
fraction after Cy-D treatment. These findings not only con-
firm the association of utrophin mRNAs with the cytoskele-
ton (Fig. 3), but further indicate that actin filaments play an
essential role in maintaining a link between these transcripts
and cytoskeletal-bound polysomes (Fig. 4 C). In these exper-
iments, we verified that the 3-h Cy-D treatment did not af-
fect the overall steady-state levels of utrophin mRNA,
thereby demonstrating that the disappearance of utrophin
transcripts from the cytoskeletal-bound polysomal fraction
could not be ascribed to a change in mRNA stability, and
that it was caused by a redistribution of the existing tran-
scripts.
On the other hand, treatment of myotubes with colchi-
cine (COL) failed to induce a redistribution of utrophin
transcripts among the distinct pools of polysomes. In these
experiments, we did verify by immunofluorescence that the
COL treatment had successfully induced the depolymeriza-
tion of microtubules (unpublished data). Because the results
are similar to those observed in control myotubes (Fig. 3),
these data indicate that the preferential localization of utro-
phin mRNAs within the cytoskeletal-bound pool of poly-
somes does not require intact microtubules.
Figure 3.  Utrophin mRNAs preferentially associate with 
cytoskeletal-bound polysomes. (A) shows a representative ethidium 
bromide–stained agarose gel of RT-PCR products corresponding to 
utrophin mRNAs obtained from free (F), cytoskeletal (C)-, and 
membrane (M)-bound polysomal fractions. The left lane is a 100-bp 
molecular mass marker. ( ), negative control lane. Note the accu-
mulation of utrophin transcripts in the cytoskeletal-bound fraction. 
(B) Utrophin transcript levels in each fraction were determined and 
expressed as a percent of the total. Shown are the results of a mini-
mum of six independent experiments.
Figure 4.  Utrophin mRNAs associate with actin microfilaments. 
(A and B) Representative examples of phalloidin-stained myotubes 
without and following exposure to Cy-D, respectively. Note the 
absence of fluorescence following Cy-D treatment. (C) Representative 
ethidium bromide-stained agarose gels of utrophin RT-PCR products 
obtained from RNA isolated from free (F), cytoskeletal (C)-, and 
membrane (M)-bound polysomes, along with a negative control ( ). 
Left panel corresponds to polysomal fractions isolated from control 
(CTL) myotubes, revealing that utrophin mRNAs preferentially asso-
ciate with the cytoskeleton. Right panel represents myotubes treated 
with CY-D showing a redistribution of utrophin mRNAs into the free 
polysomal fraction. ( ), negative control lane. The left lane is a 
100-bp molecular mass marker. Shown are representative results of 
a minimum of five independent experiments. Bar, 230  m. 
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Redistribution of utrophin transcripts during
myogenic differentiation
 
Because the association of specific mRNAs with specific sub-
cellular domains may be developmentally regulated (Cripe et
al., 1993), and because utrophin expression is moderately
increased during myogenic differentiation (Gramolini and
Jasmin, 1999), we also determined in separate experiments
 
the distribution of utrophin transcripts between the three
pools of polysomes in myoblasts versus myotubes. As shown
in Fig. 5, utrophin mRNAs are clearly not enriched in the
cytoskeletal-bound polysomal fraction in myoblasts. By
comparison to myotubes (Fig. 3), in which 
 
 
 
65% of all
utrophin mRNAs are found within cytoskeletal-bound poly-
somes, 
 
 
 
20% are present in this polysomal fraction in myo-
blasts. Therefore, these data suggest that the association of
utrophin transcripts with cytoskeletal-bound polysomes and
actin microfilaments is regulated during myogenic differen-
tiation. In contrast, agrin treatment of myotubes, which is
known to induce the formation of AChR clusters that con-
tain other synaptic components (Burden, 1998; Sanes and
Lichtmann, 1999) including utrophin (Campanelli et al.,
1994; Guo et al., 1996), failed to alter the distribution of
utrophin mRNAs amongst the three pools of polysomes
(compare Figs. 5 C and 3).
 
Role of the 3
 
 
 
UTR in targeting utrophin transcripts to 
cytoskeletal-bound polysomes
 
Given that previous studies have indicated that mRNAs as-
sociate with the cytoskeleton via their 3
 
 
 
UTR (for review see
Veyrune et al., 1997), we next investigated the role of the
3
 
 
 
UTR in the targeting of utrophin transcripts in skeletal
muscle. To this end, we isolated the utrophin 3
 
 
 
UTR by
PCR and subsequently generated 
 
 
 
-galactosidase reporter
constructs by inserting the 3
 
 
 
UTR in forward or reverse
(used as a control) orientation, downstream of the LacZ
gene (see Fig. 7 C). These expression vectors were then
transfected into skeletal muscle cells grown in culture. The
three distinct polysomal fractions were subsequently isolated
and the presence of 
 
 
 
-galactosidase transcripts was analyzed
in each fraction.
In these experiments, analysis of the various subcellular
fractions showed that the utrophin 3
 
 
 
UTR, cloned in the
forward orientation, was capable of directing 
 
 
 
-galactosidase
transcripts to the cytoskeletal pool of polysomes (Fig. 6 A).
Quantitative analyses revealed that 
 
 
 
65% of the total con-
tent of 
 
 
 
-galactosidase transcripts was present within the cy-
toskeletal-bound polysomal fraction (Fig. 6 B), a value
nearly identical to that observed for endogenous utrophin
transcripts (Fig. 3 B). In addition, we noted in these experi-
ments that disruption of the actin filament network with
Cy-D, led to a redistribution of 
 
 
 
-galactosidase transcripts
as observed with the endogenous utrophin mRNAs (com-
pare Figs. 4 and 6 A). In contrast to the localization within
the cytoskeletal-bound polysomal fraction of 
 
 
 
-galactosidase
transcripts containing the utrophin 3
 
 
 
UTR in the forward
orientation, cultures transfected with 
 
 
 
-galactosidase expres-
sion constructs containing the 3
 
 
 
UTR in the reverse orienta-
tion failed to be targeted to this pool of polysomes (Fig.
6 A). With the reverse orientation construct, we observed
that 
 
 
 
75% of all 
 
 
 
-galactosidase transcripts were enriched
within the free polysomal fraction (Fig. 6 B). This pattern of
distribution was also seen with the parental 
 
 
 
-galactosidase
expression vector that only contains its own 3
 
 
 
UTR (unpub-
lished data). As a control for these experiments, we verified
in these myotubes (except for those treated with Cy-D) that
endogenous utrophin mRNAs were indeed present within
cytoskeletal-bound polysomes. Together, these results indi-
Figure 5. Utrophin mRNAs do not preferentially associate with 
cytoskeletal-bound polysomes in myoblasts. (A) Representative 
ethidium bromide–stained agarose gels of PCR products corre-
sponding to utrophin cDNAs obtained from free (F), cytoskeletal-
bound (C), and membrane (M)-bound polysomal fractions. The left 
lane is a 100-bp molecular mass marker. ( ), negative control lane. 
Note the lack of preferential accumulation of utrophin transcripts 
within the cytoskeletal-bound fraction. (B) Utrophin transcript levels 
in each polysomal fraction were determined and expressed as a 
percent of the total. Shown are the results of a minimum of seven 
independent experiments. (C) Utrophin transcript levels in polysomal 
fractions were also determined in myotubes treated with agrin and 
expressed as a percent of the total. Shown are the results of a mini-
mum of four independent experiments.1178 The Journal of Cell Biology | Volume 154, Number 6, 2001
cate that the 3 UTR is critical in targeting utrophin tran-
scripts to their appropriate subcellular location.
Domains necessary for targeting utrophin transcripts
Having established that the full-length 3 UTR leads to an
association of utrophin mRNAs with cytoskeletal-bound
polysomes and actin filaments, we became interested in fur-
ther characterizing the region(s) within the 3 UTR necessary
for this targeting. Therefore, we generated several additional
reporter constructs that contained, downstream of the LacZ
gene, truncated fragments of the utrophin 3 UTR (Fig. 7
C). These constructs were subsequently transfected into
muscle cells, and polysomal fractions were isolated and ana-
lyzed for the presence of  -galactosidase transcripts. As illus-
trated in Fig. 7, A and B, we determined in these experi-
ments that elements contained within nucleotides 969 to
596 account for  1/2 of the localization of chimeric mRNAs
to cytoskeletal-bound polysomes. Similarly, the 3 UTR frag-
ment containing nucleotides 596–332 appeared responsible
for the remaining targeting effect, as reporter constructs con-
taining the first 332 nucleotides, or less (with constructs 161
and 86) of the 3 UTR, failed to direct  -galactosidase
mRNAs to this pool of polysomes. Therefore, a region
containing  600 nucleotides appears critical for targeting
 -galactosidase transcripts to cytoskeleton-bound polysomes.
A distinct region in the 3 UTR regulates the stability of 
utrophin transcripts
In a final series of experiments, we used the same reporter
constructs to determine the impact of the utrophin 3 UTR
on the stability of  -galactosidase transcripts. For these stud-
ies, we transfected muscle cells in culture with the various
expression vectors and subsequently exposed the cells to ac-
tinomycin D to inhibit transcription. At different time points
thereafter, muscle cell cultures were analysed to determine
the levels of  -galactosidase mRNAs. In comparison to pa-
rental  -galactosidase mRNAs, which displayed a half-life of
 4 h under these conditions, these experiments revealed
that the utrophin 3 UTR was capable of conferring a more
stable half-life to  -galactosidase transcripts (Fig. 8). Indeed,
we determined that the half-life of  -galactosidase tran-
scripts that contained the full-length utrophin 3 UTR was
 21 h (Fig. 8), a value similar to that seen recently under
similar experimental conditions for endogenous utrophin
mRNAs (Gramolini and Jasmin, 1999). Furthermore, we
also identified in these experiments a region that appears
critical for conferring this relatively stable half-life to  -galac-
tosidase transcripts. Using the different reporter constructs
containing different lengths of the utrophin 3 UTR (Fig. 7
C), we determined that constructs 86 and 161 failed to ex-
tend the longevity of  -galactosidase mRNAs, whereas the
reporter constructs containing the first 332, 596, and 969
nucleotides showed similar half-lives as those seen using the
full-length 3 UTR. Therefore, it appears that the element(s)
contained within nucleotides from position 161 to 332 in
the 3 UTR is necessary to regulate the relatively stable half-
life of utrophin transcripts in skeletal muscle cells.
Discussion
Similar to several other transcripts encoding synaptic pro-
teins in muscle (for review see Duclert and Changeux, 1995;
Burden, 1998), utrophin mRNAs display an asymmetric
distribution along skeletal muscle fibers as they accumulate
preferentially within the postsynaptic sarcoplasm (Gramo-
lini et al., 1997; Vater et al., 1998). Such a pattern of distri-
Figure 6.  The 3 UTR of utrophin mRNA targets 
LacZ transcripts to cytoskeletal-bound polysomes. 
(A) shows representative examples of ethidium 
bromide–stained agarose gels of  -galactosidase 
PCR products obtained from free (F), cytoskeletal 
(C)-, and membrane (M)-bound polysomes follow-
ing transfections with constructs containing the 
utrophin 3 UTR in the forward or reverse orienta-
tion. (Left) Muscle cultures were transfected with 
the reporter construct containing the utrophin 
3 UTR in the forward orientation. Note that in 
these myotubes, chimeric transcripts preferentially 
associate with cytoskeletal-bound polysomes. 
(Middle) Cultures were treated with Cy-D which 
disrupts this association as seen with endogenous 
utrophin mRNAs. (Right)  -galactosidase 
constructs containing the utrophin 3 UTR in the 
reverse orientation are not targeted to cytoskeletal-
bound polysomes. (B) The levels of  -galactosidase 
transcripts for each polysomal fraction were deter-
mined and expressed as a percentage of the total 
 -galactosidase mRNA levels detected. Shown are 
the results obtained from a minimum of five 
independent experiments.Targeting and stability of utrophin transcripts | Gramolini et al. 1179
bution has been shown to result, at least partially, from the
local activation of the utrophin gene in myonuclei located in
the vicinity of the postsynaptic apparatus (Gramolini et al.,
1997, 1998). However, previous studies using several other
experimental systems, have led to the notion that the com-
partmentalized expression of mRNAs in specific cellular
compartments requires their interaction with cytoskeletal el-
ements (Bassell and Singer, 1997; Bassell et al., 1999; Lip-
shitz and Smibert, 2000). Additionally, it has become appar-
ent that in the cytoplasm, specific mRNAs are localized to a
distinct class of polysomes that are attached to cytoskeletal
elements rather than localizing to free polysomes (Hesketh,
1996; Bassell and Singer, 1997). Because the postsynaptic
sarcoplasm of muscle fibers contains a differentiated set of
microtubules (Jasmin et al., 1990) as well as a specialized ac-
tin meshwork (Hall et al., 1981), we became interested in
determining whether utrophin transcripts were enriched in a
particular subcellular compartment of polysomes through
interactions with the cytoskeleton. Using a sequential deter-
gent/salt extraction procedure, we show that in myogenic
cells, utrophin mRNAs are concentrated in a pool of cyto-
skeletal-bound polysomes and that this specific enrichment
depends on the integrity of the actin microfilaments. There-
fore, it is tempting to speculate that these mechanisms also
operate in vivo and act to complement the local transcrip-
tional regulation of the utrophin gene in order to ensure the
efficient local expression of utrophin mRNAs at the neuro-
muscular junction.
In our experiments, we also observed that the association
of utrophin transcripts with cytoskeletal elements is under
developmental influence because, as opposed to our findings
with myotubes, utrophin mRNAs were clearly not enriched
within the cytoskeletal-bound polysomal fraction in undif-
ferentiated myoblasts. Interestingly, recent studies have indi-
Figure 7.  Targeting domain within the utrophin 3 UTR. (A) Representative examples of ethidium bromide–stained agarose gels corre-
sponding to  -galactosidase RT-PCR products obtained from free (F), cytoskeletal (C)-, and membrane (M)-bound polysomal fractions after 
transfections with reporter constructs containing truncated fragments of the 3 UTR. Note that  -galactosidase constructs containing nucle-
otide sequence 332–596 are still targeted to cytoskeletal-bound polysomes and that this localization is lost with a smaller 3 UTR fragment 
(332 nt). (B) The levels of  -galactosidase transcripts for each polysomal fraction were determined and expressed as percentage of the total 
 -galactosidase mRNA levels detected. Shown are representative examples of a minimum of five experiments. (C) shows the reporter 
constructs used in these studies. The utrophin 3 UTR sequences were inserted downstream of the LacZ gene. Nucleotide positions are 
denoted on the right.1180 The Journal of Cell Biology | Volume 154, Number 6, 2001
cated that other transcripts that are found in association
with distinct polysomal fractions are also regulated during
myogenic development. For example, transcripts encoding
vimentin or the poly (a )-binding protein do not show any
association with the cytoskeleton in myoblasts; however, fol-
lowing myogenic differentiation, these transcripts become
preferentially localized to the cytoskeleton (Adamou and
Bag, 1992; Cripe et al., 1993). Thus, it appears that the sub-
cellular localization of some mRNAs, including utrophin,
undergoes profound changes during remodelling of the
cytoskeleton which accompanies myogenic differentiation.
Consistent with such a mechanism, a recent study has fur-
ther revealed that actin polymerization during the early
stages of synaptogenesis acts as an intracellular scaffold that
orchestrates the assembly of the postsynaptic apparatus dur-
ing the formation and growth of the neuromuscular junc-
tion (Dai et al., 2000). As a result, it is possible that the
sorting of utrophin mRNAs to specific subcellular compart-
ments could in fact play an important role in establishing
and maintaining the local synthesis of utrophin at the neu-
romuscular junction during synapse formation.
Having established that utrophin mRNAs are specifically
targeted to a particular subcellular compartment in skeletal
muscle cells, we next investigated the mechanism by which
these transcripts are separated from those translated on the
rough endoplasmic reticulum or free polysomes. We fo-
cussed on the 3 UTR as this region is known to contain cis-
acting elements that are responsible for directing the intrac-
ellular trafficking of various mRNAs (Kim-Ha et al., 1993;
Hesketh et al., 1994; Kislauskis et al., 1994; Partridge et al.,
1999; Keibler and DesGroseillers, 2000). In our experi-
ments, the ability of the utrophin 3 UTR to redirect the lo-
calization of  -galactosidase mRNAs to cytoskeletal-bound
polysomes indicates that utrophin transcripts are subject to
an active intracellular sorting and targeting process. To char-
acterize more precisely the cis-acting elements involved in
this targeting mechanism, we generated several reporter con-
structs that contain deleted fragments of the utrophin
3 UTR and examined the polysomal association of the chi-
meric LacZ transcripts. These studies highlighted the crucial
contribution of the regions between nucleotides 332 and
969 of the utrophin 3 UTR for the targeting of LacZ mRNAs
to cytoskeletal-bound polysomes. A detailed examination of
elements contained within this region revealed the presence
of several AU-rich regions, including two adjacent ones, that
have been shown previously to be necessary for the appropri-
ate targeting of c-myc transcripts to cytoskeletal-bound poly-
somes in fibroblasts (Veyrune et al., 1996). Therefore, it ap-
pears likely that these consensus sequences are also critical in
regulating the targeting of utrophin transcripts to the cyto-
skeleton in skeletal muscle cells.
Comparison of the utrophin 3 UTR across species revealed
a very high degree of sequence homology, particularly between
nucleotides 352 and 583 of the mouse and human sequences
(Fig. 1 B). This high level of conservation suggests that this
region may indeed be critical for regulating the targeting of
utrophin transcript in both mouse and human skeletal
muscle. The exact mechanism by which these sequences act to
target transcripts to cytoskeletal-bound polysomes remains un-
known, but it is likely that specific RNA-binding proteins in-
teract with these cis-acting elements, resulting in the recruit-
ment and targeting of transcripts to the intracellular actin
network. As utrophin mRNAs are specifically targeted to cy-
toskeletal-bound polysomes in myotubes but not in myoblasts,
it appears plausible that the abundance of these RNA-binding
proteins may vary during myogenic differentiation as to cor-
rectly target utrophin transcripts to their appropriate subcellu-
lar compartment. Therefore, it will be important in future
studies to identify the putative RNA-binding proteins that in-
teract with the utrophin 3 UTR in attempts to further charac-
terize the role of the 3 UTR in the control of utrophin expres-
sion. Similarly, it may be interesting to examine whether the
5 UTR and coding sequence also plays a role in targeting utro-
phin transcripts in muscle cells, although the large size of the
coding region may make it difficult to study in its entirety.
Figure 8.  The utrophin 3 UTR regulates the stability of  -galac-
tosidase transcripts.  -Galactosidase reporter constructs containing 
the full-length utrophin 3 UTR were transfected into muscle cells in 
culture. The stability of  -galactosidase transcripts was determined 
by exposing cultures to actinomycin D at time zero. Samples were 
collected at various time points and total RNA was subsequently 
extracted and subjected to RT-PCR. A shows a representative ethid-
ium bromide-stained agarose gel corresponding to  -galactosidase 
RT-PCR products. ( ), negative lane. (B) Quantitation of these 
results revealed that the half-life of  -galactosidase transcripts 
containing the full-length utrophin 3 UTR is  22 h ( ; line 1). 
Similar results were obtained with constructs containing the first 
332 nt of the utrophin 3 UTR (lines 2, 4, and 5). Note also that the 
stability of the chimeric mRNAs was reduced with smaller frag-
ments (lines 6 and 7) or when the region from nt 1 to 969 was 
absent from the 3 UTR (line 3). Shown are the pooled results from 
four independent experiments.Targeting and stability of utrophin transcripts | Gramolini et al. 1181
It is well established that in addition to directing the sub-
cellular localization of mRNAs, the 3 UTR controls the
turnover rate of presynthesized mRNAs through interac-
tions with trans-acting factors and cytoskeletal elements
(Bassell and Singer, 1997; Tsai et al., 1997; Veyrune et al.,
1997). In recent work, we have shown that the half-life
of utrophin transcripts in skeletal muscle cells is  20 h
(Gramolini and Jasmin, 1999). In the present study, we de-
termined that specific regions of the utrophin 3 UTR were
sufficient to confer a similar and relatively stable half-life to
the LacZ transcript. In fact, deletion analyses revealed that
nucleotides between position 161 and 332 of the utrophin
3 UTR are important for mediating this effect. Interest-
ingly, this region, responsible for mediating transcript stabil-
ity, is different than the elements responsible for targeting
utrophin transcripts to the cytoskeletal-bound polysomes
(nucleotides 332–969; see above). Nonetheless, this observa-
tion is entirely consistent with previous studies that have ex-
amined the localization and stability of c-myc transcripts in
fibroblasts (Veyrune et al., 1996). In particular, mutations
of specific AU-rich regions in the c-myc 3 UTR were shown
to disrupt the subcellular targeting of the transcript without
affecting mRNA stability (Veyrune et al., 1996). It should
also be pointed out that since we were able to confer a rela-
tively stable half-life to the reporter transcripts that was
nearly identical ( 20 h) to that measured for endogenous
utrophin mRNAs under similar conditions (Gramolini and
Jasmin, 1999), it appears that the 3 UTR contains most, if
not all, the regulatory elements necessary to control the sta-
bility of utrophin transcripts in skeletal muscle cells.
Based on utrophin’s ability to functionally compensate for
the lack of dystrophin in animal models of DMD, a number
of studies have examined the regulatory events controlling
utrophin expression in skeletal muscle. Until now, these
studies have focussed primarily on transcriptional mecha-
nisms (see, for example, Gramolini et al., 1997, 1998,
1999a; Burton et al., 1999; Khurana et al., 1999; Galvagni
and Oliviero, 2000). Taken together with our recent find-
ings obtained in vivo and demonstrating the importance of
mRNA stability in the control of the levels of utrophin and
its transcript in slow versus fast muscles (Gramolini et al.,
2001), the results of the present study illustrate the key con-
tribution of posttranscriptional events in the overall regula-
tion of utrophin in skeletal muscle cells. Accordingly, these
findings provide novel targets, in addition to transcriptional
events, for which pharmacological interventions may be en-
visaged to ultimately increase the endogenous levels of utro-
phin in DMD muscle fibers.
Materials and methods
Generation of utrophin 3 UTR reporter constructs
The full-length utrophin 3 UTR was generated by reverse transcription
(RT)-PCR using RNA isolated from C2C12 cells and primers designed
against the mouse utrophin sequence (Fig. 1 A; Blake et al., 1995; Guo et
al., 1996). The 3 UTR fragment was subsequently inserted downstream of
the reporter gene LacZ in the pCMV Sport  -galactosidase expression vec-
tor (GIBCO BRL) using available NcoI and EcoRI cloning sites. Additional
constructs containing varying lengths of the utrophin 3 UTR (Fig. 7 C) were
also generated by PCR amplification. All plasmids were sequenced to ver-
ify the identity of the constructs. For both transfection and direct gene
transfer experiments, plasmid DNA was prepared using QIAGEN kits.
Tissue culture and cellular fractionation
Mouse C2C12 muscle cells were cultured, maintained, differentiated, and
transfected using calcium phosphate, as described in detail previously
(Gramolini et al., 1998). In our studies, myoblasts were examined when
they were 50% confluent, whereas myotubes were analyzed after 4 d in
differentiation media. Agrin treatment of myotubes was performed as de-
scribed in Gramolini et al. (1998). For experiments involving the inhibition
of RNA synthesis, cultures were incubated with 4  g/ml of actinomycin D
in culture media (Tennyson et al., 1996; Gramolini and Jasmin, 1999).
Samples were collected for up to 40 h after drug exposure. Unless other-
wise specified, all culture reagents were obtained from GIBCO BRL.
The procedure to isolate subcellular fractions was similar to that de-
scribed by Hesketh et al. (1994) and Hovland et al. (1995). In brief, muscle
cells were washed three times with PBS and harvested in 1.0 ml of lysis
buffer containing 10 mM Tris, pH 7.6, 0.25 M sucrose, 25 mM KCl, 5 mM
MgCl2, 0.5 mM CaCl2, and 0.5% Nonidet P-40. Lysates were then centri-
fuged at 1,000 g for 5 min and the supernatant, containing the free poly-
somal fraction, was removed and stored on ice. To isolate the cytoskele-
tal-bound polysomal fraction, the pellet was washed in lysis buffer,
resuspended in a second lysis buffer that contained 130 mM KCl and 0.5%
NP-40, and then incubated for 10 min at 4 C. The extract was centrifuged
at 2,000 g for 5 min and the supernatant removed and stored on ice. The
membrane-bound polysomal fraction was harvested by incubating at room
temperature for 15 min the cell pellet in a third lysis buffer containing 130
mM KCl, 0.5% Nonidet P-40, and 0.5% deoxycholate. This cell suspen-
sion was centrifuged at 3,000 g for 5 min and the resulting supernatant,
yielding the membrane-bound fraction, was removed and placed on ice.
An aliquot of each of the three fractions was taken to measure the activity
of LDH using a commercially available kit (Sigma-Aldrich). All fractions
were stored at  80 C for further analysis.
To examine the association of utrophin transcripts with the cytoskele-
ton, myotube cultures were treated for 3 h, before the collection of subcel-
lular fractions, with compounds known to disrupt the integrity of distinct
components of the cytoskeleton. Specifically, myotubes were treated with
2  M Cy-D (Tsakiridis et al., 1994) or 50  M COL (Bassell et al., 1994) to
depolymerize actin filaments or the microtubule network, respectively. To
verify that these drug treatments had indeed resulted in the depolymeriza-
tion of microfilaments and microtubules, myotubes were processed for
fluorescence experiments using rhodamine-conjugated phalloidin or a
monoclonal antibody directed against  -tubulin (Molecular Probes), re-
spectively.
RNA extraction and RT-PCR 
Total RNA was extracted from muscle cells in culture and from the polyso-
mal fractions using TriPure as recommended by the manufacturer (Boeh-
ringer Mannheim). Final RNA pellets were washed twice with 75% etha-
nol, resuspended in 20  l RNase-free water, and stored at  20 C. From
each stock RNA sample, the RNA was further diluted to a final concentra-
tion of 50 ng/ l. 2  l of this final dilution was used for RT-PCR. For cul-
tures transfected with  -galactosidase expression constructs, the RNA sam-
ples were treated with RQ DNase I (Promega) at 37 C for 1.5 h and then
heated at 65 C for 20 min (Boudreau-Larivière et al., 2000).
RT-PCR was used to determine the relative abundance of transcripts
among the different polysomal fractions and was performed as described in
detail elsewhere (Jasmin et al., 1995; Gramolini et al., 1998). In brief, RT
was performed for 45 min at 42 C using random hexamers, and heated to
99 C for 5 min to terminate the reaction. Utrophin cDNAs were specifically
amplified by PCR using primers designed on the basis of the mouse utro-
phin sequence as described previously (Jasmin et al., 1995; Gramolini et
al., 1998). These primers generate a 548-bp fragment. cDNAs encoding the
 -subunit of the AChR were amplified using primers designed on the basis
of the mouse sequence (5 :5 -GACTATGGAGGAGTGAAAAA-3 ; and 3 :
5 -TGGAGGTGGAAGGGATTAGC-3 ) that generate a 576-bp PCR prod-
uct. cDNAs encoding  -galactosidase were amplified as described (Bou-
dreau-Larivière et al., 2000). The primers used to amplify  -galactosidase
were 5 ; 5 -GTGACGGCAGTTATCTGG-3  and 3 :5 -ATGATGCTCGT-
GACGGTT-3 . These primers generate a 506-bp PCR product. Amplifica-
tion of the selected cDNAs was performed in a DNA thermal cycler (Perkin
Elmer Cetus Co.). Each cycle of amplification consisted of denaturation at
94 C for 1 min, primer annealing at 65 C for 1 min, and extension at 72 C
for 1 min. Typically, 26–30 cycles of amplification were performed. In sep-
arate experiments, we ascertained that these cycle numbers were within
the linear range of amplification. Negative controls consisted of RT mix-
tures in which total RNA was replaced with RNase-free water.
PCR products were visualized on a 1% agarose gel containing ethidium
bromide. The 100-bp molecular mass markers (MBI Fermentas and GIBCO1182 The Journal of Cell Biology | Volume 154, Number 6, 2001
BRL) were used to estimate the molecular mass of the PCR products. For
quantitative PCR experiments, PCR products were separated and visual-
ized on agarose gels containing the fluorescent dye Vistra green (Amer-
sham Pharmacia Biotech) as described in Gramolini et al., (1998). The la-
beling intensity of the PCR product, which is linearly related to the amount
of DNA, was subsequently quantitated using a Storm PhosphorImager and
the accompanying software (Molecular Dynamics)
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